mil. Yen % mil. Yen % mil. Yen % mil. Yen %

Similar documents
Summary of Consolidated Financial Results for the Year Ended March 31, 2015 (Based on Japanese GAAP)

Summary of Consolidated Financial Results for the Year Ended December 31, 2017 (Based on Japanese GAAP)

Consolidated Financial Results for the Fiscal Year Ended March 31, 2016 [Japanese GAAP] May 27, 2016

Summary of Consolidated Financial Results for the Year Ended March 31, 2018 (Based on Japanese GAAP)

Summary of Consolidated Financial Results for the Year Ended March 31, 2016 (Based on Japanese GAAP)

Summary of Consolidated Financial Results for the Year Ended March 31, 2015 (Based on Japanese GAAP)

CKD Corporation and Consolidated Subsidiaries. Consolidated Financial Statements for the Years Ended March 31, 2015 and 2014

Period Ending: 03/31/ /31/2015

Summary of Consolidated Financial Results for the Fiscal Year Ended March 2015 (unaudited)

(1) Consolidated Balance Sheets As of December 31, 2013 and 2014 ( ) represents negative figures. Millions of yen

Asahi Group Holdings, Ltd.

Consolidated Financial Results for the Nine Months Ended December 31, 2015 [Japanese GAAP]

FUJI YAKUHIN CO., Ltd. Consolidated Financial Statements For the Year ended March 31,2017

Summary of Consolidated Financial Results for the Year Ended March 31, 2018 (Based on Japanese GAAP)

Summary of Consolidated Financial Results for the Year Ended March 31, 2016 (Based on Japanese GAAP)

Consolidated Financial Results for the Second Quarter of Fiscal Year 2018

million yen % (39.5) 10.2 million yen 8,855 8,654

Consolidated Financial Results for the Nine Months Ended December 31, 2016 [Japanese GAAP]

Summary of Consolidated Financial Results for the Fiscal Year Ended March 2018(unaudited)

Consolidated Financial Results for the First Quarter of Fiscal Year 2017

Summary Report of Consolidated Financial Results

Consolidated Financial Results for the First Quarter of Fiscal Year 2018

FY2011 Consolidated Financial Results (Japan GAAP)

Summary of Consolidated Financial Results for the Year Ended February 28, 2017 (FY2017) (Based on Japanese GAAP)

[Translation] Code number: 1963 Representative Title: Representative Director, Chairman and Chief Executive Officer (CEO) Tel:

Consolidated Financial Statements (1) Consolidated Balance Sheet

Summary of Consolidated Financial Results for the Six Months Ended May 31, 2016 (Based on Japanese GAAP)

5. Consolidated Financial Statements (1) Consolidated Balance Sheets

Summary of Consolidated Financial Results for the First Half Ended September 30, 2008

August 11, 2014 Consolidated Cumulative 2nd quarter Financial Results for the Fiscal Year Ended December 31, 2014 (January 1, 2014 to June 30, 2014)

Summary of Consolidated Financial Results of Sumitomo Osaka Cement Co., Ltd. for the First Half of Fiscal 2019, Ending March 31, 2019 (Japan GAAP)

Summary of Consolidated Financial Results for the Six Months Ended September 30, 2015 (Based on Japanese GAAP)

Summary of Consolidated Financial Results of Sumitomo Osaka Cement Co., Ltd. for the Fiscal 2012, Ending March 31, 2012(Japan GAAP) May 11, 2012

Consolidated 2nd quarter Financial Results for the Fiscal Year Ended December 31, 2017 (January 1, 2017 to June 30, 2017)

Summary of Consolidated Financial Results for the Six Months Ended May 31, 2015 (Based on Japanese GAAP)

CKD Corporation and Consolidated Subsidiaries. Consolidated Financial Statements for the Years Ended March 31, 2016 and 2015

Asahi Group Holdings, Ltd.

Consolidated Financial Results. Fiscal year ended June 30, 2008:

Summary of Consolidated Financial Results for the Year Ended March 31, 2018 (Based on Japanese GAAP)

3. Forecast of Financial Results for the Fiscal (The percentage figures represent the percentage of increase or decrease against the same period of th

Consolidated Financial Results (Japanese GAAP) FY2017 ending March 2018 TOPCON CORPORATION Release Date: October 27, 2017

Consolidated Financial Results for the Fiscal Year Ended December 31, 2017 (January 1, 2017 to December 31, 2017)

4. Consolidated Financial Statements (1) Consolidated Balance Sheets As of December 31, 2015 ASSETS Current assets: 107, , ,066 54,075

Balance Sheet (Thousands of yen)

Summary of Consolidated Financial Statements for the Fiscal Year Ended March 2017 (Japan GAAP) May 11, 2017 Name of Listed Company:

CKD Corporation and Consolidated Subsidiaries. Consolidated Financial Statements for the Years Ended March 31, 2017 and 2016

Financial Results For the Fiscal Year 2016 ending January 31, 2016

Net sales Operating profit Ordinary profit

Summary of Financial Results for the Year Ended February 28, 2018 [Japan GAAP] (Consolidated)

Consolidated Financial Results for the six months of Fiscal Year 2017 (Fiscal Year 2017: Year ending March 31, 2017) November 8, 2016 Company Name

Net Sales Operating Profit Ordinary Profit

3. CONSOLIDATED QUARTERLY FINANCIAL STATEMENTS

Profit Change Attributable to (%) Owners of Parent Fiscal year ended June 30, Operating

Consolidated Financial Results for the Fiscal Year Ended March 31, 2017 [Japanese GAAP]

Net sales Operating profit Ordinary profit. Million yen Million yen Million yen Million yen Six months ended

Summary of Consolidated Financial Results for the Six Months Ended September 30, 2014 (Based on Japanese GAAP)

Profit Change Attributable to (%) Owners of Parent Fiscal year ended June 30, Operating

:

Summary of Consolidated Financial Results for the Year Ended March 31, 2017 (Based on Japanese GAAP)

Consolidated Financial Results for the Three Months Ended June 30, 2018 <under Japanese GAAP>

CONSOLIDATED FINANCIAL RESULTS for the Fiscal Year Ended March 31, 2015 <under Japanese GAAP>

Consolidated Financial Results for Fiscal Year 2018

Consolidated Financial Statements for the Fiscal Year Ended March 31, 2018

Summary of Consolidated Financial Results For the Fiscal Year Ended September 30, 2015 Based on Japanese GAAP

CONSOLIDATED FINANCIAL STATEMENTS These Consolidated Financial Statements were publicly released in the Japanese language on November 9, 2016.

Financial Results for FY2010 (April 1, 2009 through March 31, 2010) English Translation of the Original Japanese-Language Document May 11, 2010

Balance Sheets (Quarterly)

Consolidated Financial Results for the Year Ended February 20, 2018 [Japanese GAAP]

Net sales Operating profit Ordinary profit Profit

Summary of Consolidated Financial Results for the Year Ended November 30, 2015 (Based on Japanese GAAP)

Tera Probe, Inc. Financial Results. for the Second Quarter FY2016

Net sales Operating income Ordinary income

Summary of Consolidated Financial Results for the Six Months Ended September 30, 2018 (Based on Japanese GAAP)

FLASH REPORT May 8, 2014

Consolidated Financial Statements (1) Consolidated Balance Sheets

Consolidated Balance Sheet Thousands of yen

Consolidated Financial Statements for The Year of FY2017 (April 1, March 31, 2018)

Summary of Consolidated Financial Results for the Year Ended March 31, 2017 (Based on Japanese GAAP)

Summary of Consolidated Financial Results for the Three Months Ended June 30, 2017 (Based on Japanese GAAP)

Summary of Consolidated Financial Results for the Year Ended March 31, 2018 (Based on Japanese GAAP)

Consolidated Financial Statements Consolidated Balance Sheet

Consolidated Financial Results For the Year Ended March 31, 2018

FINANCIAL STATEMENTS FOR THE 58TH FISCAL YEAR FROM 1 APRIL, 2013 TO 31 MARCH, 2014 日東工器株式会社 NITTO KOHKI CO., LTD.

Asahi Group Holdings, Ltd.

Consolidated Financial Results for the Third Quarter Ended December 31, 2009

Summary of Consolidated Financial Results for the Nine Months Ended December 31, 2014

Consolidated Financial Results for the Fiscal Year Ended January 31, [Japanese GAAP]

Consolidated Financial Statements for The 2nd Quarter of FY2018 (April 1, September 30, 2018)

Financial Results for the Fiscal Year Ended March 31, 2010

Consolidated Financial Results for the Fiscal Year 2017 (April 1, 2017 to March 31, 2018)

Consolidated Financial Statements (1) Consolidated Balance Sheet (Unit: Million yen) Previous Consolidated Fiscal Year (Ended March 31, 2011)

August 1, 2012 Name of Listed Company: SDS Biotech K.K. Exchange: Tokyo Code Number: 4952 URL

Consolidated Financial Statements for The 2nd Quarter of FY2017 (April 1, September 30, 2017)

Consolidated Financial Results for the Second Quarter of Fiscal Year Ending March 2018 [Japan GAAP]

Consolidated Financial Statements and Primary Notes

Consolidated Financial Results for the Third Quarter Ended December 31, 2018 [ Japan GAAP ] February 7, 2019 The Sumitomo Warehouse Co., Ltd. Securiti

Million yen % Million yen % Million yen % Million yen % Six months ended September 30, 2018

FY2015 Consolidated Financial Results Japanese Standard

NOTICE OF THE 69TH ORDINARY GENERAL MEETING OF SHAREHOLDERS

Financial Results for the Year Ended March 31, 2018

Transcription:

FY2012 Financial Results Outline (Consolidated Base) (Based on Generally Accepted Accounting Principles in Japan) (Translated from the Original Japanese Document) May 11, 2012 Company Name: Uniden Corporation URL:http://www.uniden.co.jp/ Stock Code: No. 6815 Stock Listed at First Section, Tokyo Stock Exchange Representative: CEO & Representative Director, Hidero Fujimoto Contact: Director, Finance and Accounting Div, Masashi Kikumoto Phone: 81-3-5543-2800 Date of General Meeting of Shareholders: June 28, 2012 Dividend Issue Date: June 29, 2012 Annual Report Submission: June 29, 2012 Financial Results Briefing: Yes (Directed at Institutional Investors and Financial) 1. Consolidated Results for FY2012 (April 1, 2011 to March 31, 2012) (1) Consolidated Financial Results (Accumulated) (Amounts rounded less than millions) (% of change from previous fiscal year) Net Sales Operating Income Ordinary Income Net Income mil. Yen % mil. Yen % mil. Yen % mil. Yen % FY2012 33,921 10.0 590 77.2 591 560.2 371 69.8 FY2011 37,685 6.1 2,587-90 - 1,228 - (Note) Consolidated Comprehensive Income; FY2012: 341 mil yen ( 70.6%). FY2011: 1,161 mil yen (-%) Net Income per Share Net Income per Share after Adjustment of Residual Shares Return on Equity Ordinary Income/Total Asset Operating Margin Yen Yen % % % FY2012 6.30-1.1 1.5 1.7 FY2011 20.85-3.8 0.2 6.9 (2) Consolidated Financial Position Total Asset Net Asset Capital Adequacy Ratio Equity per share Million Yen Million Yen % Yen FY2012 end 39,390 32,571 82.7 553.10 FY2011 end 40,736 32,675 80.2 554.79 (Reference) Shareholders Equity; FY2012: 32,571 mil yen. FY2011: 32,675 mil yen. (3) Consolidated Cash Flow Cash Flows from Operating Activities Cash Flows from Investing Activities Cash Flows from Financing Activities ing Balance of Cash and Cash Equivalent Million Yen Million Yen Million Yen Million Yen FY2012 942 1,106 193 7,508 FY2011 2,941 3,275 8,000 7,948

2. Cash Dividends 1st Qtr 2nd Qtr Annual Dividends 3rd Qtr 4th Qtr Yen Total Amount of Dividend Payout Ratio Ratio of Dividends to Net Asset Total Million Yen % % FY2011-0.00-7.50 7.50 442 36.0 1.4 FY2012-0.00-10.00 10.00 589 158.8 1.5 FY2013 (Forecast) - - - - - (Note) FY2013 Dividends are undecided yet. 3. Forecast of Consolidated Results for FY2013 (April 1, 2012 to March 31, 2013) (% of change from, FY2012 end) Sales Operating Income Ordinary Income Net Income EPS mil. yen % mil.yen % mil. yen % mil. yen % yen FY2013 2nd Qtr 14,700 19.1 520 50.8 490 49.5 290 58.4 4.92 FY2013 Annual 31,000 9.0 1,940 165.9 1,860 154.5 1,340 162.4 22.75 (Note) Deviation from the last public disclosure of the consolidated results forecast: Yes 4. Others (1) Changes in significant subsidiaries during the current quarter: None (2) Application of specific accounting procedures for quarterly financial statements: None (3) Changes in accounting policies, changes and corrections of accounting estimates 1 Changes of accounting policies by a newly issued accounting standards: None 2 Changes of accounting policies by other than (3) 1 above: None 3 Changes of accounting estimates: None 4 Unhiding of corrections: None (4) Number of shares issued and outstanding (common stock) FY2012 FY2011 Number of shares issued and outstanding at the end of 63,139,649 63,139,649 each period (including treasury stock) Number of treasury stock at the end of each period 4,251,686 4,243,830 Av. number of shares issued & outstanding in each period 58,892,080 58,901,752 *Information Regarding the Quarterly Review Procedures This financial summary falls outside the scope of audit procedures based on the stipulations of the Financial Instruments and Exchange Act. The audit procedures for financial statements based on the stipulations of said Act were not completed at the time this financial summary was disclosed. *Cautionary Statement with Respect to Forward-Looking Statements This report contains forward-looking statements that include the company s forecasts for consolidated results based on all information and data collected by the company and judged on a premise deemed to be reasonable at present. Please note that actual performances may vary significantly depending on various factors.

Consolidated Financial Statements (1) Consolidated Balance Sheets FY2011 Fiscal Year FY2012 Fiscal Year (March 31, 2011) (March 31, 2012) Assets Current Assets Cash and Deposits 8,198 7,508 Notes and Accounts Receivable-Trade 6,895 5,525 Merchandise and Finished Goods 3,526 3,747 Work In Progress 538 736 Raw Materials and Supplies 2,539 3,002 Deferred Tax Assets 960 699 Other 709 495 Allowance for Doubtful Accounts 159 77 Total Current Assets 23,206 21,635 Fixed Assets Tangible Fixed Assets Buildings and Structures 8,677 8,848 Accumulated Depreciation 4,968 5,155 Buildings and Structures (net) 3,709 3,693 Machinery, Equipment and Vehicles 3,386 3,697 Accumulated depreciation 1,196 1,423 Machinery, Equipment andvehicles (net) 2,190 2,274 Tools, Furniture and Fixtures 6,087 6,225 Accumulated Depreciation 5,521 5,659 Tools, Furniture and Fixtures (net) 566 566 Land 9,191 9,178 Constructions In Progress 170 328 Total Tangible Fixed Assets 15,826 16,039 Intangible Fixed Assets 511 577 Investment and Other Assets Investment Securities 443 443 Others 937 811 Allowance for Doubtful Accounts 187 115 Total Investment & Other Assets 1,193 1,139 Total Fixed Assets 17,530 17,755 Total Assets 40,736 39,390

FY2011 Fiscal Year FY2012 Fiscal Year (March 31, 2011) (March 31, 2012) Liabilities Current Liabilities Notes and Accounts Payable-Trade 3,793 3,535 Accrued Expenses 1,638 1,662 Income Taxes Payable 1,333 409 Provision for Bonus 310 257 Provision for Director's Bonuses - 13 Provision for Product Warranties 136 118 Other 769 747 Total Current Liabilities 7,979 6,741 Non Current Liabilities Other 82 78 Total Non Current Liabilities 82 78 Total Liabilities 8,061 6,819 Net Assets Shareholders' Equity Capital Stock 35,999 35,999 Capital Surplus 12,233 11,791 Retained Earnings 3,139 3,510 Treasury Stock 7,316 7,319 Total Shareholders' Equity 44,055 43,981 Accumulated Other Comprehensive Income Valuation Difference on Available-for-Sales Securities 6 0 Foreign Currency Translation Adjustment 11,386 11,410 Total Accumulated other comprehensive Income 11,380 11,410 Net Assets Total 32,675 32,571 Total Liabilities and Net Assets 40,736 39,390

(2) Consolidated Income Statements FY2011 Fiscal Year FY2012 Fiscal Year March. 31, 2011) March 31, 2012) Net Sales 37,685 33,921 Cost of Sales 26,046 24,125 Gross Profit 11,639 9,796 Selling, General and Administrative Expenses 9,052 9,206 Operating Income 2,587 590 Non-operating Income Interest Income 62 30 Dividend Income 3 1 Rent Income 23 29 Interest on Refund 116 1 Gain on Adjustment of Account Payable 66 26 Insurance Income 2 37 Gain on Sales of Scraps 27 21 Other 251 40 Total Non-operating Income 550 185 Non-operating Expense Interest Expense 92 0 Foreign Exchange Losses 2,884 142 Other 71 42 Total Non-operating Expense 3,047 184 Ordinary Income 90 591 Extraordinary Income Gain on Sales of Noncurrent Assets 363 26 Gain on Liquidation of Subsidiaries - 251 Reversal of provision for product warranties 23 - Gain on Abolishment of Retirement Benefit Plan 112 - Reversal of allowance for loss on compsensation for products 264 - Gain on Prior Periods Adjustment 304 - Total Extraordinary Income 1,066 277 Extraordinary Loss Loss on Fixed Assets Disposal & Sale 43 14 Special Retirement Expenses 25 113 Settlement Package - 25 Impairment Loss - 8 Total Extraordinary Loss 68 160 Income Before Income Taxes 1,088 708 Income Taxes-Current 67 86 Refund of Income Taxes 424 - Income Taxes-Deferred 217 251 Total Income Taxes 140 337 Income Before Minority Interests 1,228 371 Net Income 1,228 371

(3) Consolidated Statements of Comprehensive Income FY2011 Fiscal Year (From Apr 1 through March 31, 2011) FY2012 Fiscal Year (From Apr 1 through March 31, 2012) Income Before Minority Interests 1,228 371 Other Comprehensive Income Valuation Difference on Available-for-Sale Securities 27 6 Foreign Currency Translation Adjustment 40 24 Other Comprehensive Income Total 67 30 Comprehensive Income 1,161 341 (Comprehensive income attribute to) Comprehensive income attribute to owners of the parent 1,161 341 Comprehensive income attribute to minority interests - -

(4) Consolidated Cash Flow March 31, 2011) March 31, 2012) Cash Flows from Operating Activities Net Income (loss) before tax adjustment 1,088 708 Depreciation and amortization 1,307 1,055 Gain on valuation of investments in securities 2 0 Gain on Liquidation of Subsidiaries - 251 Fixed asset sales and disposal income 320 11 Changes of allowance for account doubtful 29 6 Interest and dividend income 65 31 Interest expense 92 0 Currency Exchange gain and loss 3,703 144 Changes in trade receivables 1,615 1,255 Changes in inventories 852 894 Changes in trade payables 1,037 212 Others 2,542 48 Sub total 1,432 1,709 Interest and dividend received 129 31 Interest paid 94 0 Corporate tax paid or refunded 1,474 798 Cash Flows from Operating Activities 2,941 942 Cash Flows from Investing Activities Refund of time deposit 3,866 - Acquisition of tangible fixed assets expenses 718 1,104 Sales of tangible fixed assets income 550 17 Acquisition of intangible fixed assets expenses 243 85 Sales of investment securities income 34 0 Others 214 66 Cash Flows from Investing Activities 3,275 1,106 Cash Flows from Financing Activities Repayment of short term debt expenses 25,440 - Acquisition of own shares expenses 2 2 Dividends expenses 4 441 Deposit as collateral 3,680 - Withdrawal of deposit as collateral 21,126 250 Cash Flows from Financial Activities 8,000 193 Cash and cash equivalent conversion difference 730 83 Change of cash and cash equivalent 2,514 440 Opening balance of cash and cash equivalent 10,462 7,948 ing balance of cash and cash equivalent 7,948 7,508